Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.
Return to work
The Role of Supervision
A substantial body of clinical research has demonstrated that disulfiram is most effective when taken under conditions of supervision.
​
Supervision introduces:
-
accountability
-
consistency of dosing
-
early detection of non-adherence
-
structured support
-
​
This transforms disulfiram from a passive prescription into an active component of a monitored recovery programme.
The Olita Study
The Olita Study is widely referenced in addiction medicine as a demonstration of the impact of supervised disulfiram treatment.
​
The study reported significantly improved abstinence outcomes in individuals receiving supervised disulfiram compared to unsupervised approaches.
​
These findings reinforce the importance of monitoring and adherence as key determinants of treatment success.
Clinical Interpretation
Taken together, the evidence indicates:
​
- Disulfiram can be highly effective
- Effectiveness is strongly dependent on adherence
- Supervision significantly improves outcomes
This creates a clear clinical requirement:
Supporting Clinical Perspectives
ZenaMed’s approach to monitored recovery is also informed by clinical work in the field.
“Teaching an Old Dog New Tricks” — Dr Keron Fletcher
​
This paper explores the role of structured monitoring and behavioural reinforcement in supporting recovery from alcohol dependence.
​
It provides clinical insight into how adherence-based approaches can improve long-term outcomes.
Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.
Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.
Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.